Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.08% | 15.49% | 21.49% | 18.55% | 13.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.08% | 15.49% | 21.49% | 18.55% | 13.82% |
| Cost of Revenue | 8.25% | 3.37% | 8.72% | -3.40% | 14.98% |
| Gross Profit | 17.52% | 19.81% | 26.52% | 32.93% | 13.41% |
| SG&A Expenses | 9.40% | -2.93% | -12.75% | 13.59% | 6.14% |
| Depreciation & Amortization | 10.75% | -3.83% | 2.46% | -7.76% | -12.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.55% | 10.80% | 4.35% | 4.73% | 5.47% |
| Operating Income | -20.38% | 50.82% | 679.82% | 213.38% | 82.39% |
| Income Before Tax | 11.82% | 2,021.84% | 303.53% | 1,080.19% | 12.11% |
| Income Tax Expenses | -4,085.89% | -53.68% | 232.55% | 69.16% | -114.65% |
| Earnings from Continuing Operations | 64.62% | 2,701.02% | 307.36% | 704.79% | 26.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.62% | 2,701.02% | 307.36% | 704.79% | 26.28% |
| EBIT | -20.38% | 50.82% | 679.82% | 213.38% | 82.39% |
| EBITDA | -14.05% | 34.22% | 239.66% | 112.03% | 52.84% |
| EPS Basic | 60.96% | 2,649.60% | 299.67% | 688.62% | 23.53% |
| Normalized Basic EPS | -12.80% | 19.55% | 295.80% | 285.71% | 43.81% |
| EPS Diluted | 58.33% | 2,580.00% | 288.89% | 711.58% | 26.32% |
| Normalized Diluted EPS | -14.19% | 16.49% | 297.24% | 286.71% | 44.77% |
| Average Basic Shares Outstanding | 2.26% | 2.02% | 1.93% | 2.02% | 2.22% |
| Average Diluted Shares Outstanding | 3.88% | 4.68% | 1.57% | 1.85% | 1.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |